Navigation Links
Lafmin Morgan Joins Talecris Biotherapeutics as Vice President, U.S. Product Management
Date:7/8/2010

RESEARCH TRIANGLE PARK, N.C., July 8 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) today announced that Lafmin Morgan has joined the Global Commercial Operations team as vice president, U.S. Product Management.  In this role, Morgan will be responsible for product management and marketing of the company's full product portfolio in the U.S.

"Lafmin brings significant experience and leadership to Talecris and will strengthen our capabilities as we pursue the continued growth of Talecris' U.S. business," said John Perkins, executive vice president, Global Commercial Operations.

Morgan joins Talecris from GlaxoSmithKline (GSK), where he served for more than twenty years in finance, sales, commercial strategy and marketing roles across multiple therapeutic areas. His most recent role at GSK was vice president, Commercial Model Innovations, in which he led GSK's effort to build a new sales and marketing model for the company's entire U.S. business.

Prior to that, Morgan served at GSK as vice president of Sales, a position in which he managed a 2000-person sales force and served as chair of the U.S. Sales Leadership Team. He also served as vice president of Respiratory Marketing, where he implemented a marketing strategy that grew the $5 billion respiratory portfolio by 13 percent in just over one year.  

Morgan holds a Bachelor of Science in Business Administration and a Master of Business Administration from the University of North Carolina at Chapel Hill.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com


'/>"/>
SOURCE Talecris Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
2. Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged Conference
3. 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
4. Trubion Pharmaceuticals to Present at Fall 2008 Morgan Stanley Global Healthcare Unplugged Conference in New York
5. Amylin Pharmaceuticals to Present at Thomas Weisel Healthcare, BioCentury NewsMakers, and Morgan Stanley Global Healthcare Conferences
6. NeurogesX to Present at Morgan Stanley Global Healthcare Unplugged Conference
7. NuVasive to Present at Morgan Stanley Global Healthcare Unplugged Conference
8. BioMarin to Present at the Morgan Stanley Global Healthcare Conference
9. Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008
10. Hologic to Present at the Morgan Stanley Global Healthcare Unplugged Conference
11. Pharmasset to Present at the Upcoming Citibank and Morgan Stanley Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... FireflySci, Inc is an explosive ... 2014, FireflySci had the goal of bringing their powerful cuvette and spectrophotometer ... the path that FireflySci is going on as they add yet another mark on ...
(Date:2/23/2017)... and NEW YORK ... HIMSS, Lumeon , a leading digital health ... Telehealth), a provider of telemedicine and remote patient ... pathways for telemedicine reimbursements.  DN ... their patients, in real-time, extending consultations beyond a ...
(Date:2/23/2017)... JOSE, Calif. , Feb. 23, 2017 /PRNewswire/ ... exclusive license for two key immunotherapy technologies from ... first technology provides a method to monitor a ... such as PD-L1 and CTLA-4.  The second license ... if a patient is likely to have an ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... (FDA) de novo clearance to begin marketing the SPEAC® System, the Brain Sentinel® ... adults at home or in healthcare facilities during periods of rest. A lightweight, ...
Breaking Biology Technology:
(Date:2/6/2017)... -- According to Acuity Market Intelligence, ongoing concerns ... continue to embrace biometric and digital identification based ... Control (ABC) eGates and 1436 Automated Passport Control ... ports of entry across the globe. Deployments increased ... CAGR of 37%. APC Kiosks reached 75% growth ...
(Date:2/2/2017)... -- EyeLock LLC, a market leader of iris-based identity authentication ... You Should Know About Biometrics in the Cloud ."  ... a growing concern. In traditional schemes, cryptography is used ... schemes such as username/password suffer from inherent weaknesses. ... elegant solution to the problem of high-security user authentication. ...
(Date:1/30/2017)... SAN FRANCISCO , Jan. 30, 2017   ... of the fastest growing genetic information companies, today announced ... 2016 financial results and provide 2017 guidance on Monday, ... a conference call that day at 4:45 p.m. Eastern ... call, Invitae,s management team will briefly review financial results, ...
Breaking Biology News(10 mins):